Daniel Avery is a Data Analyst with the China Kadoorie Biobank at the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), University of Oxford. He graduated with an MSc in Research Methods from the University of Bristol before working for a number of companies in the retail sector performing data management roles. He is responsible for helping develop and manage the CKB database, ensuring the research team and collaborators have access to reliable and high quality data.
His primary duties include:
Developing and maintaining several of the tools used for automatic generation of datasets, as well as tools used for building and testing new data releases.
Acting as a knowledge bank for in-house researchers, about how data was gathered and managed, as well as known pitfalls or challenges associated with each data source.
Importing, cleaning and standardising information from sources as diverse as Health Insurance agencies, meteorological stations, urinalysis devices and genetic assays.
Generally trying to make the lives of CKB researchers easier.
Genome-wide polygenic risk score, cardiometabolic risk factors, and type 2 diabetes mellitus in the Chinese population.
Huang N. et al, (2023), Obesity (Silver Spring)
Associations of polygenic risk scores with risks of stroke and its subtypes in Chinese.
Yang S. et al, (2023), Stroke Vasc Neurol
Genotyping and population characteristics of the China Kadoorie Biobank.
Walters RG. et al, (2023), Cell Genom, 3
Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysis.
Yao P. et al, (2023), Int J Epidemiol, 52, 1197 - 1208
Associations of alcohol intake with subclinical carotid atherosclerosis in 22,000 Chinese adults.
Zhou T. et al, (2023), Atherosclerosis, 377, 34 - 42